Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Healthcare Economics & Policy | March 2020
Tuesday, March 24, 2020
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Economics

Top Stories

Making an impact: AHA outlines its role during COVID-19 pandemic

The American Heart Association (AHA) has shared a detailed account of its role as the world continues to fight against the spread of the new coronavirus.

READ MORE >
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
Share on Twitter Share on Facebook Share on Linkedin

Making an impact: AHA outlines its role during COVID-19 pandemic

Share on Twitter Share on Facebook Share on Linkedin
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
The American Heart Association (AHA) has shared a detailed account of its role as the world continues to fight against the spread of the new coronavirus.
READ MORE >

ACC issues COVID-19 guidance for cardiologists

Just days before the American College of Cardiology canceled its annual scientific sessions for the first time in the meeting’s 69-year history, it released a set of guidelines for cardiology care teams dealing with the COVID-19 outbreak.

READ MORE >
Coronavirus
Share on Twitter Share on Facebook Share on Linkedin

ACC issues COVID-19 guidance for cardiologists

Share on Twitter Share on Facebook Share on Linkedin
Coronavirus
Just days before the American College of Cardiology canceled its annual scientific sessions for the first time in the meeting’s 69-year history, it released a set of guidelines for cardiology care teams dealing with the COVID-19 outbreak.
READ MORE >

Judge recommends revoking license of UCLA cardiologist accused of sexual assault

A California judge is recommending that a University of California, Los Angeles cardiologist accused of sexually assaulting three women have his medical license revoked.

READ MORE >
A gavel and a stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Judge recommends revoking license of UCLA cardiologist accused of sexual assault

Share on Twitter Share on Facebook Share on Linkedin
A gavel and a stethoscope
A California judge is recommending that a University of California, Los Angeles cardiologist accused of sexually assaulting three women have his medical license revoked.
READ MORE >

America’s most expensive CV drug needs a 93% price cut

A 92.6% reduction in the list price of tafamidis—an effective but ultimately unaffordable drug designed to treat transthyretin amyloid cardiomyopathy—would be required to make the medication accessible to the average heart patient, researchers reported in Circulation Feb. 12.

READ MORE >
physician payment concept image
Share on Twitter Share on Facebook Share on Linkedin

America’s most expensive CV drug needs a 93% price cut

Share on Twitter Share on Facebook Share on Linkedin
physician payment concept image
A 92.6% reduction in the list price of tafamidis—an effective but ultimately unaffordable drug designed to treat transthyretin amyloid cardiomyopathy—would be required to make the medication accessible to the average heart patient, researchers reported in Circulation Feb. 12.
READ MORE >

Featured Articles

Non-US citizens less likely to receive treatment for CV ills

U.S.-born and -naturalized citizens are far more likely than noncitizens to receive treatment for CVD risk factors, researchers reported in Circulation this month.

READ MORE >
passport-2642172_960_720.jpg
Share on Twitter Share on Facebook Share on Linkedin

Non-US citizens less likely to receive treatment for CV ills

Share on Twitter Share on Facebook Share on Linkedin
passport-2642172_960_720.jpg
U.S.-born and -naturalized citizens are far more likely than noncitizens to receive treatment for CVD risk factors, researchers reported in Circulation this month.
READ MORE >

AHA criticized for faulty marketing partnership with Bayer

The American Heart Association is facing criticism after partnering with Bayer to promote the company’s low-dose aspirin in Walmart pharmacies across the U.S., STAT reported March 9.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

AHA criticized for faulty marketing partnership with Bayer

Share on Twitter Share on Facebook Share on Linkedin
The American Heart Association is facing criticism after partnering with Bayer to promote the company’s low-dose aspirin in Walmart pharmacies across the U.S., STAT reported March 9.
READ MORE >

Utah Supreme Court paves way for thousands to seek legal action against cardiologist

A Feb. 18 decision by the Utah Supreme Court means that more than 1,000 patients are free to pursue claims against Salt Lake City cardiologist Sherman Sorensen, who’s been accused of performing hundreds of unnecessary PFO and ASD closures.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Utah Supreme Court paves way for thousands to seek legal action against cardiologist

Share on Twitter Share on Facebook Share on Linkedin
A Feb. 18 decision by the Utah Supreme Court means that more than 1,000 patients are free to pursue claims against Salt Lake City cardiologist Sherman Sorensen, who’s been accused of performing hundreds of unnecessary PFO and ASD closures.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Preventing the most common complication after heart surgery | When bioprosthetic valves fail | Good news for Medtronic
PFA's dominance & other key EP trends | FDA approves next-gen mitral valve | Virtual nursing helps practices combat burnout
FDA's new device warning | How to implement AI-powered coronary plaque software | Key approvals for Abbott | IV fluids recalled
New SCAI president outlines focus into 2027 | DCBs have similar outcomes to DES | GLP-1s lower AFib
‘Father of modern cardiology’ dies at 96 | High-risk women missing out on care | Tirzepatide beneficial for TAVR & PCI patients
Week in Review: Cardiologist pay climbs 10% | Energy drinks & heart disease | CMS, FDA propose major change | Treating HFmrEF
Strokes after PFA | Hospital sues practice | FDA approves fast-acting drug for children | The cardiologist shortage continues

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …10
    • Page 11
    • Page 12
    • Page 13
    • Current page 14
    • Page 15
    • Page 16
    • Page 17
    • Page 18 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme